How many institutions own ITRM stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ITRM shares is 27, representing 8.58% of the company's common stock.

Who are the major shareholders selling Iterum Therapeutics plc stock?

CREATIVE FINANCIAL DESIGNS INC /ADV, in the last quarter, reduced its stake in ITRM by -100% restricting it's holding to 0 shares of worth nearly -. CYPRESS CAPITAL MANAGEMENT LLC (WY) also lessened -100% of the ITRM shares from its portfolio, reducing its holding to 0 shares of worth -. NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC also shunned ITRM shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying ITRM stock?

As per its latest 13F filing, CAPTRUST FINANCIAL ADVISORS increased its stake in ITRM by 24.19% in the last quarter. The institutional holder raised its holding to 138.6 thousand shares having worth more than $46.43K. GEN-WEALTH PARTNERS INC also added 3.15% more shares of ITRM to its portfolio, raising its holding to 84.63 thousand shares of worth $28.35K. GEN-WEALTH PARTNERS INC also increased its ITRM shares holding by 100% which brought its holding to 82.05 thousand shares worth $54.97K.

ITRM's major insiders: who are they?

The insider with the most stakes in ITRM is CANAAN X L.P. , at the company. Additionally, ITRM stock is highly held by HEALY JAMES and 10 percent owner Sofinnova Venture Partners IX, L.P. among others.

Did an insider recently sell ITRM stock?

Company executives, directors, and other insiders own 0.95% percent of Iterum Therapeutics plc's stock. Within the last six months, there have been 0 transaction(s) in which ITRM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PUTTAGUNTA SAILAJA, AHRENS BRENTON KARL, and MATTHEWS JUDITH M..

Which insider recently purchased ITRM stock?

There have been 1 transaction(s) during the past 6-months in which Iterum Therapeutics plc insiders have bought stock, totalling 6000 shares

How much of ITRM does insiders own?

Around 241K Iterum Therapeutics plc shares are held by insiders, which represents about 0.95% of ITRM stock.

Who is the insider with the largest stake?

ITRM , CANAAN X L.P. holds the largest portfolio of the company's shares. ITRM shares owned by CANAAN total nearly 1.73 million.

Which institution holds the most shares in ITRM?

CYPRESS CAPITAL MANAGEMENT LLC (WY) is the largest institutional owner in ITRM which holds 66 shares worth $22.00 or 0% of the total ITRM shares outstanding followed by CAPTRUST FINANCIAL ADVISORS with ownership of 138.6 thousand shares representing 0.3% of the ITRM ownership. GEN-WEALTH PARTNERS INC is the third largest stakeholder with 84.63 thousand shares or 0.18% of the ownership worth more than $28.35K.

Is Iterum Therapeutics plc stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ITRM is concerned, it is a stock which is not optionable.

Is there a short position on ITRM's shares?

Number of ITRM shares short is 2.08M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding ITRM shares are there?

As of today, 44.66M shares of ITRM are outstanding.

Is there many float in ITRM stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ITRM has 44.25M shares in float.

ITRM short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ITRM is 2.59.

Iterum Therapeutics (ITRM) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares4.9

Short Percent Of Float4.95

Shares Outstanding44.66M

Shares Float44.25M

Shares Short2.08M

Short Ratio2.59

4.95%

Short % of Float

4.9%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.95% Percentage of Shares held by All Insiders

8.58% Percentage of Shares held by All Institutions

8.66% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 8.58% of ITRM shares are held by financial institutions. CYPRESS CAPITAL MANAGEMENT LLC (WY) is the top corporate investor, holding 66 shares valued at $22.00. A 0% stake in Iterum Therapeutics plc is owned by the company. CAPTRUST FINANCIAL ADVISORS owns 138.6K shares valued at $46.43K, which translates its holding of 0.3% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2025	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	66	22	0	0
Dec 31, 2025	CAPTRUST FINANCIAL ADVISORS	0.3%	138.6K	46.43K	27K	+24.19%
Dec 31, 2025	GEN-WEALTH PARTNERS INC	0.18%	84.63K	28.35K	2.58K	+3.15%
Dec 31, 2025	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0%	66	22	0	0
Sep 30, 2025	GEN-WEALTH PARTNERS INC	0.21%	82.05K	54.97K	82.05K	+100.00%
Sep 30, 2025	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	66	44	66	+100.00%
Sep 30, 2025	CREATIVE FINANCIAL DESIGNS INC /ADV	0%	0	-	-76.05K	-100.00%
Sep 30, 2025	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0%	66	44	0	0
Sep 30, 2025	CAPTRUST FINANCIAL ADVISORS	0.28%	111.6K	74.77K	100.1K	+870.43%
Jun 30, 2025	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0%	66	66	0	0
Jun 30, 2025	CREATIVE FINANCIAL DESIGNS INC /ADV	0.19%	76.05K	75.67K	6.1K	+8.72%
Jun 30, 2025	CAPTRUST FINANCIAL ADVISORS	0.03%	11.5K	11.44K	11.5K	+100.00%
Mar 31, 2025	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0%	66	81	0	0
Mar 31, 2025	CREATIVE FINANCIAL DESIGNS INC /ADV	0.21%	69.95K	86.04K	10.05K	+16.77%
Mar 31, 2025	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	0	-	-66	-100.00%
Mar 31, 2025	NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC	0%	0	-	-13	-100.00%
Mar 31, 2024	ANCORA ADVISORS, LLC	0%	38	59	0	0
Mar 31, 2024	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0%	66	102	66	+100.00%
Mar 31, 2024	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	0	-	-66	-100.00%
Dec 31, 2023	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	66	130	0	0
Dec 31, 2023	ANCORA ADVISORS, LLC	0%	38	75	0	0
Sep 30, 2023	CYPRESS CAPITAL MANAGEMENT LLC (WY)	0%	66	53	0	0
Sep 30, 2023	ANCORA ADVISORS, LLC	0%	38	30	0	0

Insiders

Among the ITRM insiders holding of 0.95% of the stake in company, CANAAN X L.P., , holds the largest shares of 1.73M. HEALY JAMES, , is the second largest ITRM insider with ownership of 1.73M shares. SOFINNOVA VENTURE PARTNERS IX, L.P., 10 percent owner, stands third with possession of 1.23M shares of that stake.

Insiders	Designation	Shares Held
CANAAN X L.P.		1.73M
HEALY JAMES		1.73M
SOFINNOVA VENTURE PARTNERS IX, L.P.	10 percent owner	1.23M
CHIN MARK	director	1.09M
LATHI VIJAY K	10 percent owner	384.62K
HUNT RONALD		384.62K
HERON PATRICK J		341.16K
DUNNE MICHAEL W.	director	241K
MATTHEWS JUDITH M.	Chief Financial Officer	65.29K
FISHMAN COREY N.	Chief Executive Officer	54.45K
MALIK SHAHZAD	director	29.84K
EDICK PAUL R	director	25.24K
KELLY DAVID GEORGE	director	19.55K
PUTTAGUNTA SAILAJA	Chief Medical Officer	4.97K
DENNER ALEXANDER J	10 percent owner	0
AHRENS BRENTON KARL	director	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 18, 2025	DUNNE MICHAEL W.	PURCHASE	0.37	6K	2.19K	241K
Aug 08, 2025	DUNNE MICHAEL W.	PURCHASE	0.72	15K	10.85K	235K
Dec 22, 2023	DUNNE MICHAEL W.	PURCHASE	1.40	25K	35K	113.75K
Dec 18, 2023	DUNNE MICHAEL W.	PURCHASE	1.84	10K	18.44K	88.75K
Nov 22, 2023	DUNNE MICHAEL W.	PURCHASE	2.03	20K	40.69K	78.75K
Nov 20, 2023	FISHMAN COREY N.	PURCHASE	1.59	10K	15.86K	54.45K
Dec 02, 2022	PUTTAGUNTA SAILAJA	SALE	1.32	3.37K	4.44K	4.97K
Sep 20, 2022	AHRENS BRENTON KARL	SALE	1.78	7.25K	12.91K	0
Sep 19, 2022	AHRENS BRENTON KARL	SALE	1.77	15K	26.48K	7.25K
Sep 16, 2022	AHRENS BRENTON KARL	SALE	1.90	15K	28.54K	22.25K
Sep 15, 2022	AHRENS BRENTON KARL	SALE	2.02	15K	30.27K	37.25K
Sep 14, 2022	AHRENS BRENTON KARL	SALE	2.10	15K	31.46K	52.25K
Sep 13, 2022	AHRENS BRENTON KARL	SALE	2.14	15K	32.12K	67.25K
Sep 12, 2022	AHRENS BRENTON KARL	SALE	2.31	15K	34.61K	82.25K
Sep 09, 2022	AHRENS BRENTON KARL	SALE	2.32	15K	34.73K	97.25K
Sep 08, 2022	AHRENS BRENTON KARL	SALE	2.26	3.3K	7.47K	112.25K
Sep 07, 2022	DUNNE MICHAEL W.	PURCHASE	2.22	10K	22.2K	35.58K
Mar 14, 2022	MATTHEWS JUDITH M.	SALE	0.31	63.34K	19.64K	65.29K
Mar 11, 2022	MATTHEWS JUDITH M.	SALE	0.38	47.13K	17.91K	81.5K
Feb 12, 2021	DENNER ALEXANDER J	SALE	2.27	10.62M	24.11M	0
Feb 11, 2021	DENNER ALEXANDER J	SALE	2.59	10M	25.9M	10.62M
Jan 26, 2021	MATTHEWS JUDITH M.	SALE	1.73	33.87K	58.59K	28.63K
Jan 26, 2021	FISHMAN COREY N.	SALE	1.73	85.45K	147.82K	322.01K
Jan 26, 2021	DUNNE MICHAEL W.	SALE	1.73	33.14K	57.34K	256.36K
Oct 27, 2020	DUNNE MICHAEL W.	PURCHASE	0.65	46.16K	30K	46.16K
Sep 30, 2020	MATTHEWS JUDITH M.	SALE	1.64	56.13K	92.05K	0
Jun 02, 2020	SOFINNOVA VENTURE PARTNERS IX, L.P.	SALE	1.61	400K	642.96K	1.23M
Jun 01, 2020	SOFINNOVA VENTURE PARTNERS IX, L.P.	SALE	1.69	100K	169.12K	1.63M
Nov 30, 2018	KELLY DAVID GEORGE	PURCHASE	6.29	10K	62.89K	19.55K
Oct 30, 2018	CHIN MARK	PURCHASE	6.10	58K	353.8K	1.09M
Sep 04, 2018	DUNNE MICHAEL W.	PURCHASE	10.00	500	5K	147.96K
Aug 27, 2018	DUNNE MICHAEL W.	PURCHASE	10.00	500	5K	147.46K
Aug 24, 2018	DUNNE MICHAEL W.	PURCHASE	10.00	500	5K	146.96K
Aug 23, 2018	EDICK PAUL R	PURCHASE	10.44	500	5.22K	25.24K
Aug 17, 2018	FISHMAN COREY N.	PURCHASE	8.73	2K	17.47K	239.95K
May 30, 2018	AHRENS BRENTON KARL	PURCHASE	13.00	506.66K	6.59M	1.73M
May 30, 2018	DUNNE MICHAEL W.	PURCHASE	13.00	2K	26K	146.46K
May 30, 2018	FISHMAN COREY N.	PURCHASE	13.00	3K	39K	237.95K
May 30, 2018	MATTHEWS JUDITH M.	PURCHASE	13.00	4K	52K	56.13K
May 30, 2018	HERON PATRICK J	PURCHASE	13.00	101.15K	1.31M	341.16K
May 30, 2018	HEALY JAMES	PURCHASE	13.00	500K	6.5M	1.73M
May 30, 2018	HUNT RONALD	PURCHASE	13.00	384.62K	5M	384.62K
May 30, 2018	SOFINNOVA VENTURE PARTNERS IX, L.P.	PURCHASE	13.00	500K	6.5M	1.73M
May 30, 2018	CANAAN X L.P.	PURCHASE	13.00	506.66K	6.59M	1.73M
May 30, 2018	CHIN MARK	PURCHASE	13.00	337.61K	4.39M	1.03M
May 30, 2018	LATHI VIJAY K	PURCHASE	13.00	384.62K	5M	384.62K
May 30, 2018	MALIK SHAHZAD	PURCHASE	13.00	8.14K	105.87K	29.84K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE6K1

SALES00

NET SHARES6K1

SHARES HELD241K1

% NET SHARES-97.51%0%

ITRM Stock Ownership Breakdown